798 related articles for article (PubMed ID: 20378860)
1. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
[TBL] [Abstract][Full Text] [Related]
2. Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.
Li H; Zuo S; He Z; Yang Y; Pasha Z; Wang Y; Xu M
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1772-81. PubMed ID: 20870802
[TBL] [Abstract][Full Text] [Related]
3. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
[TBL] [Abstract][Full Text] [Related]
4. C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction.
Zhang Z; Zhu L; Feng P; Tan Y; Zhang B; Gao E; Wang X; Fan C; Wang X; Yi W; Sun Y
Cell Death Dis; 2019 Jul; 10(7):530. PubMed ID: 31296837
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.
Chen JJ; Zhou SH
Cardiol J; 2011; 18(6):675-81. PubMed ID: 22113756
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model.
Kim SW; Lee DW; Yu LH; Zhang HZ; Kim CE; Kim JM; Park TH; Cha KS; Seo SY; Roh MS; Lee KC; Jung JS; Kim MH
Cardiovasc Res; 2012 Sep; 95(4):495-506. PubMed ID: 22886775
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium.
Zhang D; Fan GC; Zhou X; Zhao T; Pasha Z; Xu M; Zhu Y; Ashraf M; Wang Y
J Mol Cell Cardiol; 2008 Feb; 44(2):281-92. PubMed ID: 18201717
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9.
Huang W; Wang T; Zhang D; Zhao T; Dai B; Ashraf A; Wang X; Xu M; Millard RW; Fan GC; Ashraf M; Yu XY; Wang Y
Stem Cells Dev; 2012 Mar; 21(5):778-89. PubMed ID: 21671800
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction.
Meng X; Li J; Yu M; Yang J; Zheng M; Zhang J; Sun C; Liang H; Liu L
J Cell Physiol; 2018 Jan; 233(1):587-595. PubMed ID: 28322445
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction.
Grauss RW; Winter EM; van Tuyn J; Pijnappels DA; Steijn RV; Hogers B; van der Geest RJ; de Vries AA; Steendijk P; van der Laarse A; Gittenberger-de Groot AC; Schalij MJ; Atsma DE
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2438-47. PubMed ID: 17644573
[TBL] [Abstract][Full Text] [Related]
13. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction.
Chen L; Zhang Y; Tao L; Yang Z; Wang L
Cardiovasc Drugs Ther; 2017 Feb; 31(1):9-18. PubMed ID: 27913896
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction.
Zhao X; Zhang W; Xing D; Li P; Fu J; Gong K; Hage FG; Oparil S; Chen YF
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H590-8. PubMed ID: 23771691
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium.
Ju C; Shen Y; Ma G; Liu Y; Cai J; Kim IM; Weintraub NL; Liu N; Tang Y
J Cardiovasc Transl Res; 2018 Oct; 11(5):420-428. PubMed ID: 30232729
[TBL] [Abstract][Full Text] [Related]
17. Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells.
Chacko SM; Khan M; Kuppusamy ML; Pandian RP; Varadharaj S; Selvendiran K; Bratasz A; Rivera BK; Kuppusamy P
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1263-73. PubMed ID: 19286938
[TBL] [Abstract][Full Text] [Related]
18. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.
Huang P; Wang L; Li Q; Tian X; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Cheng K; Qian L; Yang Y
Cardiovasc Res; 2020 Feb; 116(2):353-367. PubMed ID: 31119268
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells.
Bortolotti F; Ruozi G; Falcione A; Doimo S; Dal Ferro M; Lesizza P; Zentilin L; Banks L; Zacchigna S; Giacca M
Circulation; 2017 Oct; 136(16):1509-1524. PubMed ID: 28754835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
